TrialMultiple sclerosis (Houndmills, Basingstoke, England)2024

Bexarotene leads to durable improvements in visual evoked potential latency: A follow-up study of the Cambridge Centre for Myelin Repair One trial.

Christopher E McMurran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.